Proponents claim it benefits consumers with knowledge of various illnesses and the possible treatments available to them. While opponents argue the negative connotations of drug abuse, increased drug costs and long term health concerns. As with any issue like this, ethics come into question; Is this ethically
This will also improve patient outcome drastically. The healthcare is a holistic entity which involves both the treatment of acute consequences of poor health the prevention of poor health from occurring (Martone 1992). The more successful the HCO is in preventing disease, the more successful they will be in improving patient health (Carlyon 1984). This goes a long way to prove that disease prevention fits nicely into the mission statement of the HCO which says that healthcare organizations do their best to promote healthy living. Ethically, it is the duty of the HCO’s under the umbrella of the CDC, to design/develop strategies to prevent diseases.
He suggested that without physician buy-in the plan wouldn’t work. He also shared the Board would not support an idea that secures funding through banks, because they believed that donors would not give once this happened. Dr. Bernauer suggested that selling Glen River to a for-profit hospital management company or making it a profit making hospital owned by the doctors would fix the problem (Drucker, 2009). Dr. Bernauer’s comments contained some truth, but they were slightly short sighted. Robbins and Judge (2011) emphasize the importance of group understanding and buy-in for organizational decisions.
Crescordia should choose to sit out on the alleged revolution because it maintains their reputation as a quality manufacturer and improvements on resorbable products cannot be made until surgeons test these tools on actual patients. Crescordia would have to invest large amounts of capital in order to develop and produce resorbable devices on a large scale. Releasing a faulty product could bring about lawsuits against the company, which would only add to the costs of launching this new line of products. Crescordia’s CFO, Calvin Westbrook, pointed out that margins will not be significant because retooling resorbables will be a huge capital expense. The legal implications of targeting specific groups are evident, especially with kids and elders as legal counsel, Sam Maddox stated.
The American Economy Stance Paper #3 Universal Healthcare The United States proudly proclaims itself as a free-market society without a managed economy. This proclamation can be put into question when government officials are calling for healthcare to be managed as a socialist program. There are inherent flaws in attempting to provide every citizen in the United States with free healthcare. Firstly, it would cause the American people’s already high taxes to skyrocket all the more; it would contribute to the degradation of quality within our healthcare system, and it would create extremely long waiting lists for any patient that might need urgent care. First and foremost, creating a system in which healthcare is “free” is incredibly misleading.
The reason for limiting amount of contingency fees in medical malpractice cases are victims have a right to a reasonable fee and it is essential to preserve that right as stated by American Bar Association http://apps.americanbar.org/tips/contingent/MedMalReport092004DCW2.pdf. It also prevents unreasonable fee prices which causes burdens not only on people, but health care systems. Medical professionals complain that excessive judgments and fees has caused costs to rise along with premiums which support pay outs. Model Rule [of Professional Conduct] 1.5 requires that the fee, whether based on an hourly rate, a contingent percentage or some other basis, "shall be reasonable. ", DR 2-106 prohibits a "clearly excessive fee," which is in turn defined as a "fee ... in excess of a reasonable fee."
The Competitive Market Model and U.S. Health Care Pharmaceuticals Government involvement and its pros and cons Pharmaceuticals plays a key role in health care, with health care being a social right it proposes government to be involved in the drug markets. States are responsible for maintaining the product safety, quality, efficacy, and keeping health costs fair to the society. Price consideration may be under government intervention. When government intervenes in pricing, it sets a standard price for the drug throughout the country so that everyone can have equitable access to these medications. This also includes the affordability range, and it stops unnecessary consumption, limits price growth to avoid excess societal burden.
Ethical promotion requires pharmaceutical companies to provide exact product facts, without recommending “off-label” use, i.e., promoting a product outside its specified FDA-approved label and guidelines for distribution, handling, etc. (Public). “Off-label promotion can be prosecuted as a criminal offense because of the potential for serious adverse health consequences to patients from such promotional activities” (Public). Even though the practice of “off-label” pharmaceutical promotion is against FDA regulations, in December of 2010, the well-known drug company Abbott and Elan was fined $41MM and $204 MM in two separate cased for utilizing this practice. In addition, AstraZeneca was fined earlier that year $520 MM in a case involving Seroquel XR (Public).
In order to provide free education for medical students, malpractice insurance for physicians, and free health care for everyone, taxes need to be raised. Ultimately, all Americans can have health care if we pay higher taxes instead of paying the insurance companies. Bibliography 1. Karen Davis, Cathy Schoen, & Kristof Stremikis, Mirror, Mirror on the Wall How the Performance of the U.S. Health Care System Compares Internationally 2010, http://www.commonwealthfund.org/~/media/Files/Publications/Fund%20Report/2010/Jun/1400_Davis_Mirror_Mirror_on_the_wall_2010.pdf. 2.
Conflict of interest is a major ethical issue that challenges health care providers, and we must deal with this ethical issue in a professional way. Health care institutions should develop policies and regulations, and provide education to health care providers about this area. However, prescription patterns are still often influenced by drug companies through the provision of gifts, dinners, funding, and financial assistance, as well as travel for prescribing doctors and nurses, or accommodation at scientific meetings. Inexpensive gifts, limited hospitality, and travel sponsorship are acceptable, and our professional associations set out clear criteria. Professional codes of practice ban lavish gifts or inducements from pharmaceutical companies, and prohibit company representatives from offering them.